Pediatric Gastroenterologists' Practice Styles and Compliance With European/North American Helicobacter pylori Guidelines

Objective This study aims to determine pediatric gastroenterologists' adherence to the management, diagnosis, and treatment of <i>Helicobacter pylori</i> (<i>H. pylori</i>) per the joint European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) guidelines for <i>H. pylori </i>in children (update 2016). Methods A survey was sent to the pediatric gastroenterology listserv to assess the knowledge of guidelines, workup, and treatment of <i>H. pylori</i> infection. The survey was open to respondents between 4/13/2022 and 5/12/2022. Results A total of 302 individuals completed the survey, representing 25 countries. The most ordered test for <i>H. pylori</i> was the stool antigen test (n = 151, 56.62%), followed by upper endoscopy (n = 97, 32.12%). Based on positive non-invasive test, 123 (40.72%) providers would never or not often treat <i>H. pylori</i>. Most providers treat <i>H. pylori</i> on histopathology in the absence of peptic ulcer disease. The majority of providers did not send <i>H. pylori</i> susceptibility testing. Most waited for the appropriate time after discontinuing antibiotics/anti-acid medication prior to testing for <i>H. pylori.</i> In the absence of susceptibility testing, 121 (40.5%) providers utilized proton pump inhibitors, amoxicillin, and clarithromycin to treat <i>H. pylori</i> compared to 79 (26.4%) providers who utilized proton pump inhibitors, high-dose amoxicillin, and metronidazole. Conclusion Areas where gastroenterologists adhere to the 2016 guidelines include waiting time after stopping antibiotics/anti-acid therapy and testing for eradication. Pediatric gastroenterologists had less adherence with the use of non-invasive testing for the diagnosis of <i>H. pylori</i>, treatment based on non-invasive test, diagnosis of <i>H. pylori</i> by endoscopy, utilizing culture and susceptibility testing, and antibiotic regimen used to treat <i>H. pylori</i>. Our survey results indicate that pediatric gastroenterologists require further education, especially now that the updated 2024 guidelines have been released.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-12-20
DOI
https://doi.org/10.7759/cureus.99707
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pediatric Gastroenterologists' Practice Styles and Compliance With European/North American Helicobacter pylori Guidelines

Héctor E. Alcalá, Lesley Small‐Harary, Anupama Chawla, Ankit Agrawal
Cureus
Helicobacter pylori-related gastroenterology studies
article

Pediatric Gastroenterologists' Practice Styles and Compliance With European/North American Helicobacter pylori Guidelines

Héctor E. Alcalá, Lesley Small‐Harary, Anupama Chawla, Ankit Agrawal
article en

Abstract

Objective This study aims to determine pediatric gastroenterologists' adherence to the management, diagnosis, and treatment of <i>Helicobacter pylori</i> (<i>H. pylori</i>) per the joint European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) guidelines for <i>H. pylori </i>in children (update 2016). Methods A survey was sent to the pediatric gastroenterology listserv to assess the knowledge of guidelines, workup, and treatment of <i>H. pylori</i> infection. The survey was open to respondents between 4/13/2022 and 5/12/2022. Results A total of 302 individuals completed the survey, representing 25 countries. The most ordered test for <i>H. pylori</i> was the stool antigen test (n = 151, 56.62%), followed by upper endoscopy (n = 97, 32.12%). Based on positive non-invasive test, 123 (40.72%) providers would never or not often treat <i>H. pylori</i>. Most providers treat <i>H. pylori</i> on histopathology in the absence of peptic ulcer disease. The majority of providers did not send <i>H. pylori</i> susceptibility testing. Most waited for the appropriate time after discontinuing antibiotics/anti-acid medication prior to testing for <i>H. pylori.</i> In the absence of susceptibility testing, 121 (40.5%) providers utilized proton pump inhibitors, amoxicillin, and clarithromycin to treat <i>H. pylori</i> compared to 79 (26.4%) providers who utilized proton pump inhibitors, high-dose amoxicillin, and metronidazole. Conclusion Areas where gastroenterologists adhere to the 2016 guidelines include waiting time after stopping antibiotics/anti-acid therapy and testing for eradication. Pediatric gastroenterologists had less adherence with the use of non-invasive testing for the diagnosis of <i>H. pylori</i>, treatment based on non-invasive test, diagnosis of <i>H. pylori</i> by endoscopy, utilizing culture and susceptibility testing, and antibiotic regimen used to treat <i>H. pylori</i>. Our survey results indicate that pediatric gastroenterologists require further education, especially now that the updated 2024 guidelines have been released.

CureusVol. 17(12)
Johnson University (US), Long Beach Animal Hospital (US), Stony Brook Children's Hospital (US), University of Maryland, College Park (US)
Openalex Percentile: Top 39%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.